Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like New model for lung cancer screening eligibility more accurate than current USPSTF method October 9, 2023 New AI tool could aid in the diagnosis of enigmatic rare diseases October 10, 2023 Father’s diet before conception influences children’s health June 5, 2024
New model for lung cancer screening eligibility more accurate than current USPSTF method October 9, 2023